Merck announces a quarterly dividend of $0.85 per share
Payment will be made on October 7, 2026, to shareholders of record on September 15, 2026.
Latest Merck News & Updates
See the latest news and media coverage for Merck. We track all announcements, press releases, and industry mentions in real time, all in one place.
Research-intensive biopharmaceutical company
merck.com- Headquarters
- Rahway, United States
- Company type
- Public company
- Number of employees
- 40,000+
- Industry
- Pharmaceuticals
Last updated
Latest news about Merck
In short: Merck secured several FDA approvals for Keytruda and Lipfendra, launched major acquisitions, and reported positive Phase 3 HIV trial data.
Company announcements
Merck announces access plans for alimatravir PrEP candidate
Voluntary licensing for 129 countries, early manufacturing investment, and regional capacity building aim to ensure rapid access if approved.
Merck's LIPFENDRA approved by FDA for LDL-C reduction
The oral PCSK9 inhibitor showed significant LDL-C reductions in Phase 3 trials, offering a new option for hypercholesterolemia.
Merck reports Phase 3 data on once-weekly oral HIV treatment
The investigational combination of islatravir and lenacapavir maintained viral suppression at 48 weeks in two trials.
Media coverage
BMS granted FDA review for label expansion of Merck-partnered anemia therapy
Bristol-Myers Squibb (BMY) has won FDA review for a marketing application seeking a label expansion for its Merck (MRK)-partnered anemia drug Reblozyl.
Merck posts—then pulls—trial plan for PD-1xVEGF and TROP2 ADC combination
After keeping tight-lipped for nearly two years, Merck & Co. briefly dropped the first concrete hint as to where it intends to take its PD-1xVEGF...
Merck (MRK) Says KEYTRUDA Beat Chemotherapy In Phase 3 Endometrial Cancer Trial
Merck (NYSE:MRK) reported that KEYTRUDA met its primary endpoint of progression free survival in the...
U.S. measles cases top 2025 total, hit 35-year high
The U.S. has recorded more than 2,300 measles cases this year, already exceeding the 2025 total of 2,289 with four months to spare.
Never miss news about Merck
Track Merck and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Merck competitors & trending companies
Browse news for competitors to Merck and other trending companies.